Benefit versus toxicity risk of digoxin in patients with COVID-19

Letter highlights concerns for digoxin use, including issues such as risk of an interaction with hydroxychloroquine, azithromycin or lopinavir/ritonavir, inhibition of digoxin metabolism due to increased cytokine levels, and AF and electrolyte imbalance due to COVID-19.

European Journal of Hospital Pharmacy